Polymorphisms in the Cytotoxic T Lymphocyte Antigen-4 Gene Region Confer Susceptibility to Addison’s Disease

Author:

Blomhoff Anne1,Lie Benedicte A.2,Myhre Anne G.3,Kemp E. Helen4,Weetman Anthony P.4,Akselsen Hanne E.1,Huseby Eystein S.5,Undlien Dag E.1

Affiliation:

1. Institute of Medical Genetics (A.B., H.E.A., D.E.U.), Ullevål University Hospital, University of Oslo, 0315 Oslo, Norway

2. Institute of Immunology (B.A.L.), Rikshospitalet University Hospital, 0027 Oslo, Norway

3. Departments of Paediatrics and Clinical Molecular Biology (A.G.M.), Akershus University Hospital, 1474 Nordbyhagen, Norway

4. Division of Clinical Sciences (North) (E.H.K., A.P.W.), University of Sheffield, Sheffield S5 7AU, United Kingdom

5. Division of Endocrinology, Institute of Medicine (E.S.H.), Haukland University Hospital, N-5021 Bergen, Norway

Abstract

Abstract The cytotoxic T lymphocyte antigen-4 (CTLA4) gene on chromosome 2q33 encodes a key regulator in the adaptive immune system. The CTLA4 surface molecule is expressed on activated T lymphocytes and involved in down-regulation of the immune response. Previous studies on a possible association between autoimmune Addison’s disease and CTLA4 polymorphisms have shown conflicting results. A recent study identified new candidate polymorphisms in the CTLA4 region, influencing gene splicing and thereby the relative abundance of soluble CTLA4. We genotyped 134 patients with Addison’s disease and 413 healthy controls from Norway and United Kingdom for these newly identified polymorphisms. Our data demonstrate that the same polymorphisms that have recently been demonstrated to confer susceptibility to autoimmune thyroid disease and type 1 diabetes also confer susceptibility to Addison’s disease. This finding suggests that polymorphisms in CTLA4 confer general risk to develop autoimmunity and identifies a potential therapeutic target in the prevention of autoimmune endocrine disorders.

Publisher

The Endocrine Society

Subject

Biochemistry, medical,Clinical Biochemistry,Endocrinology,Biochemistry,Endocrinology, Diabetes and Metabolism

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3